Recent Press Releases & News
CGTX earnings at a glance
Cognition Therapeutics, Inc. (CGTX) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$0.07, compared with -$0.06 in the same quarter last year (-17%). Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±6.6% on average; after the most recent report on Aug 6, 2026 it moved -4.4%. CGTX beat the consensus EPS estimate in 5 of its last 6 reported quarters. The share price of $0.72 sits near its 52-week low.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | $-0.04 | $-0.06 | +33.3% | +45.5% | -4.4% | earnings |
| Thu May 7, 2026 | Mar/2026 | $-0.05 | $-0.06 | +16.7% | +64.3% | +4.3% | earnings |
| Thu Mar 26, 2026 | 8K 2026-03-26 | $-0.02 | $-0.06 | +66.7% | — | -2.7% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-0.06 | $-0.07 | +14.3% | — | -1.8% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | $-0.11 | $-0.12 | +8.3% | — | +11.5% | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.14 | $-0.12 | -16.7% | — | -15.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.18 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.27 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.22 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.16 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.21 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | -$0.07 | -$0.06 | -16.7% |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-8M | $-9M | — | $-6M | $-14M | $-14M | — | $-14M |
| Net income | $-4M | $-5M | — | $-5M | $-7M | $-8M | — | $-10M |
| EPS (diluted) | $-0.04 | $-0.05 | — | $-0.06 | $-0.11 | $-0.14 | — | $-0.25 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $34M | $31M | $37M | $39M | $11M | $16M | $25M | $22M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $38M | $36M | $48M | $43M | $19M | $23M | $30M | $27M |
| Total assets | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $6M | $14M | $7M | $13M | $11M | $11M | $13M |
| Total equity | $33M | $30M | $34M | $37M | $7M | $12M | $19M | $14M |
Implied volatility — last 90 days
No IV snapshots yet for CGTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
CGTX earnings FAQ
When is CGTX's next earnings date?
Cognition Therapeutics, Inc. is expected to report on November 5, 2026.
How does CGTX stock usually react to earnings?
Across the last 6 reports the average next-day move was ±6.6%, up 2 times and down 4 times.
What EPS are analysts expecting from Cognition Therapeutics, Inc.?
The consensus estimate is -$0.07 per share, versus -$0.06 a year ago.